![]() |
|
|
Molecular Pharmacology, Vol 13, 671-678, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Pharmacology and Biochemistry, Central Research Laboratories, Yamanouchi
Pharmaceutical Company, Ltd., Itabashi-ku, Tokyo, Japan
The molecular mechanism by which N6-2'-O-dibutyryladenosine cyclic 3',5'-monophosphate inhibits oxytocin-induced contraction of the rat uterus was studied. Cyclic AMP
enhanced calcium uptake by the microsomal fraction from rat uterus over a range of
ATP concentrations. In the presence of 250 µM ATP, which is almost identical with the
intracellular concentration, the uptake reaction responded maximally and specifically
to cyclic AMP, with an apparent Ka of about 1 µM, the concentration required for half-maximal activation. Uterine mitochondrial calcium uptake could easily be distinguished from the microsomal activity, either by the inhibitory effect of sodium azide or
by the lack of effect of cyclic AMP. When microsomes were phosphorylated endogenously
with [
-32P]ATP, phosphorylation of a microsomal protein with a molecular weight of
48,000, referred to as protein A, depended upon cyclic AMP. The correlation coefficient
between cyclic AMP-dependent protein A phosphorylation and cyclic AMP-stimulated
calcium uptake was 0.968 (p < 0.01). These results suggest that the inhibition by
dibutyryl cyclic AMP of oxytocin-induced contraction of the rat uterus may be due at
least partly to the stimulation of microsomal calcium uptake mediated by cyclic AMP-dependent phosphorylation of protein A.
Note:
ACKNOWLEDGMENT
We wish to thank Miss Yasuko Matsuda for her
excellent assistance.